US And EU Approvals In First Half 2021 Underscore US-First Orientation Of Novel Drug Development

 
• By Bridget Silverman and Neena Brizmohun
US & EU Approvals
Fifty-five novel products were approved in either the US or EU during the first half of 2021.

More from Approvals

More from Product Reviews